O	0	1	A
O	2	12	randomized
O	13	18	trial
O	19	21	of
O	22	30	exercise
O	31	33	on
B-condition	34	38	well
I-condition	38	39	-
I-condition	39	44	being
I-condition	45	48	and
I-condition	49	57	function
O	58	67	following
O	68	74	breast
O	75	81	cancer
O	82	89	surgery
O	89	90	:
O	91	94	the
O	95	102	RESTORE
O	103	108	trial
O	108	109	.

O	110	114	This
O	115	120	study
O	121	126	aimed
O	127	129	to
O	130	139	determine
O	140	143	the
O	144	150	effect
O	151	153	of
O	154	155	a
O	156	164	moderate
O	164	165	,
O	166	174	tailored
O	175	183	exercise
O	184	191	program
O	192	194	on
O	195	201	health
O	201	202	-
O	202	209	related
O	210	217	quality
O	218	220	of
O	221	225	life
O	225	226	,
O	227	235	physical
O	236	244	function
O	244	245	,
O	246	249	and
O	250	253	arm
O	254	260	volume
O	261	263	in
O	264	269	women
O	270	279	receiving
O	280	289	treatment
O	290	293	for
O	294	307	nonmetastatic
O	308	314	breast
O	315	321	cancer
O	321	322	.

B-eligibility	323	328	Women
I-eligibility	329	332	who
I-eligibility	333	337	were
I-eligibility	338	344	within
I-eligibility	345	346	4
I-eligibility	346	347	-
I-eligibility	347	349	12
I-eligibility	350	355	weeks
I-eligibility	356	358	of
I-eligibility	359	366	surgery
I-eligibility	367	370	for
I-eligibility	371	376	stage
I-eligibility	377	378	I
I-eligibility	378	379	-
I-eligibility	379	382	III
I-eligibility	383	389	breast
I-eligibility	390	396	cancer
O	397	401	were
O	402	412	randomized
O	413	415	to
O	416	422	center
O	422	423	-
O	423	428	based
B-intervention	429	437	exercise
I-intervention	438	441	and
I-intervention	442	452	lymphedema
I-intervention	453	462	education
O	463	475	intervention
O	476	478	or
B-control	479	486	patient
I-control	487	496	education
O	496	497	.

O	498	508	Functional
O	509	519	assessment
O	520	522	of
O	523	529	cancer
O	530	537	therapy
O	537	538	-
O	538	544	breast
O	545	551	cancer
O	552	553	(
O	553	557	FACT
O	557	558	-
O	558	559	B
O	559	560	)
O	560	561	,
O	562	563	6
O	563	564	-
O	564	567	min
O	568	572	walk
O	572	573	,
O	574	577	and
O	578	581	arm
O	582	588	volume
O	589	593	were
O	594	603	performed
O	604	606	at
O	607	608	3
O	608	609	-
O	609	614	month
O	615	624	intervals
O	625	632	through
O	633	635	18
O	636	642	months
O	642	643	.

O	644	652	Repeated
O	653	661	measures
O	662	670	analysis
O	671	673	of
O	674	684	covariance
O	685	688	was
O	689	693	used
O	694	696	to
O	697	702	model
O	703	706	the
O	707	712	total
O	713	719	meters
O	720	726	walked
O	727	731	over
O	732	736	time
O	736	737	,
O	738	742	FACT
O	742	743	-
O	743	744	B
O	745	751	scores
O	751	752	,
O	753	756	and
O	757	760	arm
O	761	767	volume
O	767	768	.

O	769	775	Models
O	776	780	were
O	781	789	adjusted
O	790	793	for
O	794	802	baseline
O	803	814	measurement
O	814	815	,
O	816	824	baseline
O	825	833	affected
O	834	837	arm
O	838	844	volume
O	844	845	,
O	846	852	number
O	853	855	of
O	856	861	nodes
O	862	869	removed
O	869	870	,
O	871	874	age
O	874	875	,
O	876	880	self
O	880	881	-
O	881	889	reported
O	890	898	symptoms
O	898	899	,
O	900	908	baseline
O	909	911	SF
O	911	912	-
O	912	914	12
O	915	921	mental
O	922	925	and
O	926	934	physical
O	935	944	component
O	945	951	scores
O	951	952	,
O	953	958	visit
O	958	959	,
O	960	963	and
O	964	973	treatment
O	974	979	group
O	979	980	.

O	981	983	Of
O	984	987	the
O	988	997	recruited
B-total-participants	998	1001	104
O	1002	1007	women
O	1007	1008	,
B-total-participants	1009	1011	82
O	1012	1021	completed
O	1022	1025	all
O	1026	1028	18
O	1029	1035	months
O	1035	1036	.

O	1037	1041	Mean
O	1042	1045	age
O	1046	1047	(
O	1047	1052	range
O	1052	1053	)
O	1054	1057	was
B-age	1058	1060	53
I-age	1060	1061	.
I-age	1061	1062	6
I-age	1063	1064	(
I-age	1064	1066	32
I-age	1066	1067	-
I-age	1067	1069	82
I-age	1069	1070	)
I-age	1071	1076	years
O	1076	1077	;
O	1078	1080	88
O	1080	1081	%
O	1082	1086	were
B-ethinicity	1087	1096	Caucasian
O	1096	1097	;
O	1098	1100	45
O	1100	1101	%
O	1102	1106	were
O	1107	1115	employed
O	1116	1120	full
O	1121	1125	time
O	1125	1126	;
O	1127	1129	44
O	1129	1130	%
O	1131	1135	were
O	1136	1146	overweight
O	1146	1147	;
O	1148	1151	and
O	1152	1154	28
O	1154	1155	%
O	1156	1161	obese
O	1161	1162	.

O	1163	1176	Approximately
O	1176	1177	,
O	1178	1180	46
O	1180	1181	%
O	1182	1185	had
O	1186	1192	breast
O	1192	1193	-
O	1193	1203	conserving
O	1204	1211	surgery
O	1211	1212	;
O	1213	1215	79
O	1215	1216	%
O	1217	1220	had
O	1221	1229	axillary
O	1230	1234	node
O	1235	1245	dissection
O	1245	1246	;
O	1247	1249	59
O	1249	1250	%
O	1251	1259	received
O	1260	1272	chemotherapy
O	1272	1273	;
O	1274	1277	and
O	1278	1280	64
O	1280	1281	%
O	1282	1290	received
O	1291	1300	radiation
O	1300	1301	.

O	1302	1305	The
O	1306	1318	intervention
O	1319	1327	resulted
O	1328	1330	in
O	1331	1333	an
O	1334	1341	average
O	1342	1350	increase
O	1351	1353	of
O	1354	1356	34
O	1356	1357	.
O	1357	1358	3
O	1359	1361	ml
O	1362	1363	(
O	1363	1365	SD
O	1366	1367	=
O	1368	1370	12
O	1370	1371	.
O	1371	1372	8
O	1372	1373	)
O	1374	1380	versus
O	1381	1388	patient
O	1389	1398	education
O	1399	1400	(
O	1400	1401	p
O	1402	1403	=
O	1404	1405	0
O	1405	1406	.
O	1406	1408	01
O	1408	1409	)
O	1409	1410	.

B-outcome	1411	1418	Changes
I-outcome	1419	1421	in
I-outcome	1422	1426	FACT
I-outcome	1426	1427	-
I-outcome	1427	1428	B
I-outcome	1429	1435	scores
O	1436	1439	and
B-outcome	1440	1443	arm
I-outcome	1444	1451	volumes
O	1452	1456	were
O	1457	1460	not
O	1461	1474	significantly
O	1475	1484	different
O	1484	1485	.

O	1486	1490	With
O	1491	1495	this
O	1496	1501	early
O	1502	1510	exercise
O	1511	1523	intervention
O	1524	1529	after
O	1530	1536	breast
O	1537	1543	cancer
O	1544	1553	diagnosis
O	1553	1554	,
O	1555	1556	a
O	1557	1568	significant
O	1569	1580	improvement
O	1581	1584	was
O	1585	1593	achieved
O	1594	1596	in
B-outcome	1597	1605	physical
I-outcome	1606	1614	function
O	1614	1615	,
O	1616	1620	with
O	1621	1623	no
O	1624	1631	decline
O	1632	1634	in
O	1635	1641	health
O	1641	1642	-
O	1642	1649	related
B-outcome	1650	1657	quality
I-outcome	1658	1660	of
I-outcome	1661	1665	life
O	1666	1668	or
O	1669	1680	detrimental
O	1681	1687	effect
O	1688	1690	on
B-outcome	1691	1694	arm
I-outcome	1695	1701	volume
O	1701	1702	.

O	1703	1711	Starting
O	1712	1713	a
O	1714	1724	supervised
O	1725	1733	exercise
O	1734	1741	regimen
O	1742	1746	that
O	1747	1749	is
O	1750	1758	tailored
O	1759	1761	to
O	1762	1764	an
O	1765	1775	individual
O	1775	1776	'
O	1776	1777	s
O	1778	1786	strength
O	1787	1790	and
O	1791	1798	stamina
O	1799	1805	within
O	1806	1807	3
O	1808	1814	months
O	1815	1824	following
O	1825	1831	breast
O	1832	1838	cancer
O	1839	1846	surgery
O	1847	1854	appears
O	1855	1859	safe
O	1860	1863	and
O	1864	1867	may
O	1868	1874	hasten
O	1875	1887	improvements
O	1888	1890	in
O	1891	1899	physical
O	1900	1911	functioning
O	1911	1912	.
